Vietnam's biopharmaceutical sector is one of the highest growth markets in the Asia Pacific region, with a projected value surpassing $16B by 2026. Economic growth and rising income levels are driving public and private investment in knowledge-based, innovative sectors and in particular biopharmaceuticals. Mr. Do Xuan Tuyen, Deputy Minister of Health of Vietnam, will give an overview of current government initiatives to support biopharma innovation and investment. Attendees will learn about Vietnam's strategic importance and competitive advantages to invest in Asia Pacific's rising star.